T&L티앤엘
340570 · KOSDAQ · ₩340570 · 티앤엘
- Market cap
- ₩394B
- Enterprise value
- ₩361B
- P/E
- 11.4×
- P/B
- 1.8×
- Dividend yield
- 3.1%
- ROE
- 15.4%
- Net margin
- 19.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−31.6% from the high
₩21,812Today: ₩24,150 – ₩24,700₩35,800
Returns
- 1W−5.4%
- 1M−13.7%
- 3M−15.4%
- 6M−20.6%
- YTD−1.3%
- 1Y+2.0%
- Volume today
- 24,874
- 0.4× the 20-day average
- Traded today
- ₩608M
- Listed shares
- 16,070,120
- EPS (12 months)
- ₩2,154
- Earnings yield 8.8%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 31 of 100 (50 is a normal day for this stock).
- MomentumWeak-11.4% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
T&L stock overview
T&L (티앤엘, KRX: 340570) is listed on KOSDAQ, in the Biotech & Pharma sector. The company is a Korean specialty materials firm that applies high-performance materials to medical products. Its shares closed at ₩24,500 on Oct 27, 2026, up 2.08% on the day, giving it a market value of ₩394B.
Key facts
- Market cap
- ₩394B
- Sector
- Biotech & Pharma
- Latest price change
- +2.08%
- As of
- Oct 27, 2026
- Main business
- The company is a Korean specialty materials firm that applies high-performance materials to medical products.
Quick answers about T&L
- What does T&L do?
- The company is a Korean specialty materials firm that applies high-performance materials to medical products. Its main business is wound dressings, including hydrocolloid dressings, polyurethane foam dressings, hydrogel and silicone dressings, and alginate dressings, which are used to protect wounds and manage exudate. It also makes microneedle products and orthopedic fixation materials such as casts and splints, and sells cosmetic products, with exports making up most of its sales.
- What is the market cap of T&L?
- The market capitalisation of T&L was ₩394B at the close on Oct 27, 2026.
- Who are the largest shareholders of T&L?
- According to the latest official filings, the largest reported holders are Choi Yoon-so (23.97%, as of Aug 10, 2026); Choi Hyun-jun (11.36%, as of Aug 10, 2026); Pyeon Do-gi (2.45%, as of Aug 10, 2026).
- When is the next earnings report from T&L?
- Korean companies rarely announce results dates in advance. Based on when T&L filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
- Does the National Pension Service own T&L?
- Yes. The National Pension Service held 0.99% of T&L shares as of Dec 31, 2025.
Company profile
The company is a Korean specialty materials firm that applies high-performance materials to medical products. Its main business is wound dressings, including hydrocolloid dressings, polyurethane foam dressings, hydrogel and silicone dressings, and alginate dressings, which are used to protect wounds and manage exudate. It also makes microneedle products and orthopedic fixation materials such as casts and splints, and sells cosmetic products, with exports making up most of its sales.
Written by AI from the company's latest annual report.
- Korean name
- 티앤엘
- Sector
- Biotech & Pharma
- Themes
- Pharmaceuticals
- CEO
- 최윤소
- Founded
- Jun 1998
- Listed
- Nov 2020
- Listed shares
- 16,070,120
- Fiscal year ends
- Month 12
- Website
- www.tnl.co.kr/
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Trust Contract Termination Result ReportSep 23, 2026
- Amended: Half-year report (Jun 2026)Aug 21, 2026
- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- Insider shareholding reportAug 10, 2026
- Insider shareholding reportAug 10, 2026
Titles in Korean until English translations are added.
Also known as: T&L / 티앤엘 / 340570 / KRX:340570
Source: KRX statistical information